Reprogramming vectors

IN597606BActive Publication Date: 2026-07-31TOUCHLIGHT IP LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202047047702
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-04-05
Filing Date
2020-11-02
Publication Date
2026-07-31
Estimated Expiration
2039-04-05
Patent Text Reader

Abstract

Reprogramming allows the "conversion" of any mature or somatic cell of the human or animal body into a pluripotent stem cell. Reprogramming can be performed through the introduction of exogenous factors, usually transcription factors, into the mature cell. This process allows the production of induced pluripotent stem cells without the use of embryos, with the advantage that they can be produced from an individual to return / re-implant to the same individual.The inventors have developed a method of transient expression of exogenous reprogramming factors using a transient vector, wherein the vector is a closed linear DNA. Surprisingly, pluripotent stem cells developed in this manner are stable and closer in phenotype to natural stem cells such as ESCs.
Need to check novelty before this filing date? Find Prior Art